CERN Supported Research Uses New Approach to Calculate Drug Doses for Ependymoma Treatment
— Categories: CERN Research Articles Posted on May 10, 2016
St. Jude Children’s Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a phase I clinical trial of a chemotherapy, 5-FU, for ependymoma treatment.
The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients. Supported by the CERN Foundation.